Legislation increases state’s ability to investigate long-term care facilities … Illinois lawmakers set spring deadline to pass nursing home reform plan … Idaho officials find one in four COVID deaths...
Also in the News for Friday, March 19
Mar 19, 2021
LTC enforcement proponent Xavier Becerra confirmed as HHS secretary … Watchdog knocks HHS — again — for failure to adopt and track key nursing home reform strategies … COVID-19 reinfection...
Arthritis drug Actemra in short supply as demand for use in COVID ramps up
By
Alicia Lasek
Aug 18, 2021
Demand for Actemra IV has skyrocketed due to the latest wave of COVID-19 infections and hospitalizations, drugmaker Genentech says. In the past two weeks alone, orders for the drug shot up to 400% of pre-COVID...
Clinical briefs for Friday, Feb. 18
By
Amy Novotney
Feb 18, 2022
CDC reforming COVID-19 guidance … Nearly three-quarters of the U.S. now estimated to be immune to omicron variant … Brain synapse destruction culprit behind Alzheimer’s cognitive decline … Treatment...
Medical liability premiums increase by highest rate in 15 years
By
Kimberly Marselas
Mar 30, 2021
A national analysis finds liability premiums increased for nearly one-third of healthcare providers in 2020.
‘We don’t want to be abandoned again’: Providers fear federal COVID support will go away with PHE
May 24, 2022
Nursing home providers are afraid the support the industry has received during the COVID-19 pandemic will be non-existent once the public health emergency declaration comes to a close — despite a historic...
SavaSeniorCare to drop 48 facilities, aims to increase worker pay and benefits
By
Danielle Brown
Nov 04, 2020
In a bid to boost employee pay and benefits, hire infection preventionists and invest more in doctors, technology and equipment, SavaSeniorCare on Tuesday announced it will be acting to get out of 48 skilled...
HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...
FDA set to approve two COVID-19 antiviral pills this week
By
Alicia Lasek
Dec 22, 2021
FDA is expected to grant emergency use authorization to two antiviral COVID-19 pills this week, possibly as early as today, according to Bloomberg News, citing sources familiar with the matter.
COVID-19 rapid test makers struggling to meet demand
Jan 21, 2022
However, government’s order for the free test kits is in addition to existing supply and does not interfere with existing orders